✦ LIBER ✦

P4-405: A multinational, randomized, double-blind, placebo-controlled, parallel-group trial of memantine extended-release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease

✍ Scribed by Grossberg, George; Manes, Facundo; Allegri, Ricardo; Gutierrez Robledo, Luis Miguel; Gloger, Sergio; Xie, Lei; Jia, Xinwei Daniel; Perhach, James; Graham, Stephen M.

Book ID: 123157050
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 60 KB
Volume: 4
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2008.05.2476

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response across multiple outcome measure

Response across multiple outcome measures in a randomized trial of extended-release memantine (28 mg, once daily) in patients with moderate-to-severe Alzheimer's disease

✍ Graham, Stephen; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Tocco, Mi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Effects of extended-release memantine (2

Effects of extended-release memantine (28 mg, once daily) on language and communication abilities in a randomized trial of patients with moderate-to-severe Alzheimer's disease

✍ Tocco, Michael; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Graham, St 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Efficacy of high-dose, extended-release

Efficacy of high-dose, extended-release memantine (28 mg, once daily): Post hoc responder analysis from a randomized trial in patients with moderate to severe Alzheimer's disease

✍ Graham, Stephen; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Tocco, Mi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Extended-Release Memantine (28 mg, Once

Extended-Release Memantine (28 mg, Once Daily) Provides Behavioral Benefits Across a Wide Range of Disease Severity in Patients With Moderate to Severe Alzheimer's Disease: Post Hoc Analysis From a Randomized Trial

✍ Graham, Stephen M.; Hendrix, Suzanne; Miller, Michael L.; Pejović, Vojislav; Toc 📂 Article 📅 2013 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 49 KB

Clinical benefits of extended-release me

Clinical benefits of extended-release memantine (28 mg, once daily) as a function of disease severity in people with moderate to severe Alzheimer's disease: Post hoc analysis from a randomized trial

✍ Tocco, Michael; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Graham, St 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Effects of extended-release memantine (2

Effects of extended-release memantine (28 mg/day) on activities of daily living in patients with moderate to severe alzheimer's disease: Post hoc factor analysis of a randomized trial

✍ Tocco, Michael; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Graham, St 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 118 KB